Yes, it reinforces the CSL brand as an ethical investment and consolidates its share price amongst a large number of institutional investors and super funds.
BTW I have accumulated over the last few weeks in anticipation of a boost in SP come Feb 18. I am not the only one that thinks CSL is now way undervalued.
https://www.fnarena.com/index.php/2021/02/10/five-quality-companies-mistreated-by-the-market/
ABC News: Inside CSL, where Australia's Oxford-AstraZeneca vaccines are being made, page-7
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$304.41 |
Change
2.110(0.70%) |
Mkt cap ! $147.1B | |||
| Open | High | Low | Value | Volume |
| $301.24 | $306.40 | $300.65 | $201.4M | 661.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 922 | $304.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $304.44 | 38 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |